Therefore, inhibition of ERK1/2 activation seems to serve as an upstream event explaining the antiglycolytic and cytotoxic roles of curcumin in prostate carcinoma cells preadapted to acidic conditions. This evidence concerns the gene MAPK3 and prostate carcinoma.